{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:13:10Z","timestamp":1790413990093,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metast Rev"],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf01307180","type":"journal-article","created":{"date-parts":[[2005,4,3]],"date-time":"2005-04-03T06:16:25Z","timestamp":1112508985000},"page":"237-248","source":"Crossref","is-referenced-by-count":203,"title":["Hemostatic alterations in cancer patients"],"prefix":"10.1007","volume":"11","author":[{"given":"Frederick R.","family":"Rickles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"654","volume-title":"Clinique Medicale de l'Hotel-Dieu de Paris","author":"A Trousseau","year":"1865","unstructured":"TrousseauA: Phlegmasia alba dolens. In: Clinique Medicale de l'Hotel-Dieu de Paris. JB Balliere et Fils, Paris, vol 3, pp 654?712, 1865"},{"key":"CR2","volume-title":"Hemostasis and thrombosis","author":"FR Rickles","year":"1992","unstructured":"RicklesFR, EdwardsRL: Leukocytes and tumor cells in thrombosis. In: ColmanRW, HirshJ, MarderVJ, SalzmanEW (eds) Hemostasis and thrombosis, 3rd Edition. J.B. Lippincott Co, Philadelphia, 1992, in press","edition":"3rd Edition"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-2007-1002760","volume":"14","author":"FR Rickles","year":"1988","unstructured":"RicklesFR, HancockWW, EdwardsRL, ZacharskiLR: Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and\/or antiplatelet drugs in cancer treatment. Sem Thromb Hem 14: 88?94, 1988","journal-title":"Sem Thromb Hem"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ajcp\/71.1.10","volume":"71","author":"NC Sun","year":"1979","unstructured":"SunNC, McAfeeWM, HumGH, WeinerJM: Hemostatic abnormalities in malignancy, a prospective study in one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol 71: 10?16, 1979","journal-title":"Am J Clin Pathol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ajcp\/88.5.596","volume":"88","author":"RL Edwards","year":"1987","unstructured":"EdwardsRL, RicklesFR, MoritzTE, HendersonWG, ZacharskiLR, FormanWB, CornellCJ, ForcierRJ, O'DonnellJF, HeadleyE, KimSH, O'DellR, TornyosK, KwaanHC: Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 88: 596?602, 1987","journal-title":"Am J Clin Pathol"},{"key":"CR6","first-page":"499","volume":"139","author":"S Carlsson","year":"1973","unstructured":"CarlssonS: Fibrinogen degradation products in serum from patients with cancer. Acta Chir Scand 139: 499?502, 1973","journal-title":"Acta Chir Scand"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000205392","volume":"81","author":"K Okajima","year":"1989","unstructured":"OkajimaK, OkabeH, InoueM, TakasukiK: Characterization of the fibrinolytic state by measuring stable crosslinked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia. Acta Haematologica 81: 15?18, 1989","journal-title":"Acta Haematologica"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V62.1.14.14","volume":"62","author":"FR Rickles","year":"1983","unstructured":"RicklesFR, EdwardsRL: Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62: 14?31, 1983","journal-title":"Blood"},{"key":"CR9","first-page":"136","volume":"62","author":"T Wajima","year":"1989","unstructured":"WajimaT, MukhopadhyayP: Serial coagulation profiles in patients with small cell carcinoma of the lung. Thromb Haemostas Suppl 62: 136, 1989 (Abstract)","journal-title":"Thromb Haemostas Suppl"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jnci\/80.2.90","volume":"80","author":"LR Zacharski","year":"1988","unstructured":"ZacharskiLR, MoritzTE, BaczekLA, RicklesFR EdwardsRL, FormanWB, ForcierRJ, CornellCJ, HaakensonCM, BallardHS, CrumED, JohnsonGJ, LevineJ, HongWK, O'DonnellJF, SchilskyRL, RingenbergQS, RobertF, SpauldingMB, TornyosK, WilliamsC, ZuckerS, FaulknerCS, EatonWL, HoppelCL: Effect of Mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188. J Nat Ca Instit 80: 90?97, 1988","journal-title":"J Nat Ca Instit"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/1097-0142(197502)35:2<432::AID-CNCR2820350219>3.0.CO;2-6","volume":"35","author":"H Al-Mondhiry","year":"1975","unstructured":"Al-MondhiryH, LawlorBA, SadulaD: Fibrinogen survival and fibrinolysis in acute leukemia. Cancer 35: 432?435, 1975","journal-title":"Cancer"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/1097-0142(197803)41:3<1113::AID-CNCR2820410346>3.0.CO;2-D","volume":"41","author":"GH Lyman","year":"1978","unstructured":"LymanGH, BettigoleRE, RobsonE, AmbrusJL, UrbanH: Fibrinogen kinetics in patients with neoplastic disease. Cancer 41: 1113?1122, 1978","journal-title":"Cancer"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0038-1653457","volume":"46","author":"Y Yoda","year":"1981","unstructured":"YodaY, AbeT: Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease. Thromb Haemostas 46: 706?709, 1981","journal-title":"Thromb Haemostas"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V60.2.381.381","volume":"60","author":"G Mombelli","year":"1982","unstructured":"MombelliG, RouxA, HaeberliA, StraubPW: Comparison of125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasia. Blood 60: 381?388, 1982","journal-title":"Blood"},{"key":"CR15","first-page":"5","volume":"96","author":"FW Peuscher","year":"1980","unstructured":"PeuscherFW, CletonFJ, ArmstrongL, Stoepman-van DalenEA, vanMourikJA, vanAkenWG: Significance of plasma fibrinopeptide A (FPA) in patients with malignancy. J Lab Clin Med 96: 5?14, 1980","journal-title":"J Lab Clin Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/blood.V57.3.518.518","volume":"57","author":"TJ Myers","year":"1981","unstructured":"MyersTJ, RicklesFR, BarbC, CronlundM: Activation of blood coagulation in acute leukemia ? fibrinopeptide A (FPA) generation as an indicator of disease activity. Blood 57: 518?525, 1981","journal-title":"Blood"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1097-0142(19830115)51:2<301::AID-CNCR2820510223>3.0.CO;2-7","volume":"51","author":"FR Rickles","year":"1983","unstructured":"RicklesFR, EdwardsRL, BarbC, CronlundM: Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide A generation and tumor growth. Cancer 51: 301?307, 1983","journal-title":"Cancer"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.V64.4.791.791","volume":"64","author":"KA Bauer","year":"1984","unstructured":"BauerKA, RosenbergRD: Thrombin generation in acute promyelocytic leukemia. Blood 64: 791?796, 1984","journal-title":"Blood"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1200\/JCO.1987.5.12.1998","volume":"12","author":"S Nand","year":"1987","unstructured":"NandS, FisherSG, SalgiaR, FisherRI: Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications. J Clin Oncol 12: 1998?2003, 1987","journal-title":"J Clin Oncol"},{"key":"CR20","first-page":"336","volume":"17","author":"MJ Auger","year":"1987","unstructured":"AugerMJ, GallowayMJ, LeinsterSJ, McVerryBA, MackieMJ: Elevated fibrinopeptide A levels in patients with clinically localized breast carcinoma. Haemostasis 17: 336?339, 1987","journal-title":"Haemostasis"},{"key":"CR21","first-page":"253","volume":"20","author":"AK Lindahl","year":"1990","unstructured":"LindahlAK, SandsetPM, AbildgaardU: Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction. Haemostasis 20: 253?262, 1990","journal-title":"Haemostasis"},{"key":"CR22","first-page":"183","volume":"4","author":"A Gadducci","year":"1991","unstructured":"GadducciA, BaicchiU, delBravoB: The assessment of the hemostasis system in patients with ovarian and cervical carcinoma. The Cancer J 4: 183?187, 1991","journal-title":"The Cancer J"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0049-3848(90)90119-W","volume":"59","author":"T Uchiyama","year":"1990","unstructured":"UchiyamaT, MatsumotoM, KobayashiN: Studies of the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy. Thromb Res 59: 955?965, 1990","journal-title":"Thromb Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1097-0142(19900815)66:4<716::AID-CNCR2820660420>3.0.CO;2-B","volume":"66","author":"TC Abshire","year":"1990","unstructured":"AbshireTC, GoldSH, OdomLF, CarsonSD, HathawayWE: The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis? Cancer 66: 716?721, 1990","journal-title":"Cancer"},{"key":"CR25","first-page":"65","volume":"14","author":"RL Bick","year":"1988","unstructured":"BickRL: Disseminated intravascular coagulation and related syndromes: a clinical review. Sem Thromb Hem 14: 65?81, 1988","journal-title":"Sem Thromb Hem"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0049-3848(80)90330-8","volume":"18","author":"RN Rubin","year":"1980","unstructured":"RubinRN, KiesMS, PoschJJ: Measurements of antithrombin III in solid tumor patients with and without hepatic metastases. Thromb Res 18: 353?360, 1980","journal-title":"Thromb Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0038-1653396","volume":"46","author":"H Honegger","year":"1981","unstructured":"HoneggerH, AndersonN, HewittLA, TullisJL: Antithrombin III profiles in malignancy, relationship to primary tumors and metastatic sites. Thromb Haem 46: 500?503, 1981","journal-title":"Thromb Haem"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood.V63.4.965.965","volume":"63","author":"F Rodeghiero","year":"1984","unstructured":"RodeghieroF, MannucciPM, ViganoS, BarbuiT, GugliottaL, CortellaroM, DiniE: Liver dysfunction rather than intravascular coagulations as the main cause of low protein C and antithrombin III in acute leukemia. Blood 63: 969?969, 1984","journal-title":"Blood"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.2830370305","volume":"37","author":"K Troy","year":"1991","unstructured":"TroyK, EssexD, RandJ, LemaM, CuttnerJ: Protein C and S levels in acute leukemia. Am J Hematol 37: 159?162, 1991","journal-title":"Am J Hematol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/1097-0142(19901201)66:11<2387::AID-CNCR2820661123>3.0.CO;2-U","volume":"66","author":"JD Sweeney","year":"1990","unstructured":"SweeneyJD, KillionKM, PruetCF, SpauldingMB: von Willebrand factor in head and neck cancer. Cancer 66: 2387?2389, 1990","journal-title":"Cancer"},{"key":"CR31","doi-asserted-by":"crossref","unstructured":"Falanga A, Levine M, Edwards RL, Moritz TE, Zacharski LR, Rickles FR: Clotting studies in cancer patients. Report from the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis. In preparation, 1992","DOI":"10.1055\/s-0038-1649619"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0038-1645699","volume":"63","author":"RL Edwards","year":"1990","unstructured":"EdwardsRL, MorganDL, RicklesFR: Animal tumor procoagulants: Resistry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haem 63: 133?138, 1990; Edwards RL, Silver J, Rickles FR: Human tumor procoagulants. Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Subcommittee, International Society on Thrombosis and Haemostasis. Thromb Haem, Submitted for Publication","journal-title":"Thromb Haem"},{"key":"CR33","first-page":"202","volume":"29","author":"RL Edwards","year":"1992","unstructured":"EdwardsRL, RicklesFR: The role of leukocytes in the activation of blood coagulation. Sem Hematol 29: 202?212, 1992","journal-title":"Sem Hematol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V79.3.543.543","volume":"79","author":"M Tallman","year":"1992","unstructured":"TallmanM and KwaanHC: Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 79: 543?553, 1992","journal-title":"Blood"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(19870215)59:4<748::AID-CNCR2820590414>3.0.CO;2-E","volume":"59","author":"K Andoh","year":"1987","unstructured":"AndohK, KkubotaT, TakadaM, TanakaH, KobayashiN, MaekawaT: Tissue factor activity in leukemic cells. Special reference to disseminated intravascular coagulation. Cancer 59: 748?754, 1987","journal-title":"Cancer"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0038-1647454","volume":"65","author":"T Kubota","year":"1991","unstructured":"KubotaT, AndohK, SadakataH, TanakaH, KobayashiN: Tissue factor released from leukemic cells. Thromb Haem 65: 59?63, 1991","journal-title":"Thromb Haem"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood.V71.4.870.870","volume":"71","author":"A Falanga","year":"1988","unstructured":"FalangaA, AlessioMG, DonatiMB, BarbuiT: A new procoagulant in acute leukemia. Blood 71: 870?875, 1988","journal-title":"Blood"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0038-1647145","volume":"64","author":"MB Donati","year":"1990","unstructured":"DonatiMB, FalangaA, ConsonniR, AlessioG, BassanR, BuelliM, BorinL, CataniL, PoglianiE, GugliottaL, MaseraG, BarbuiT: Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haem 64: 11?16, 1990","journal-title":"Thromb Haem"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0002-9343(88)90420-2","volume":"84","author":"F Cozzolino","year":"1988","unstructured":"CozzolinoF, TorciaM, MilianiA, CarossinoAM, GiordaniR, CinottiS, FilimbertiE, SaccardiR, BernabeiP, GuidiG, DiGuglielmoR, PistoiaV, FerrariniM, NawrothPP, SternD: Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 84: 240?250, 1988","journal-title":"Am J Med"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V73.3.800.800","volume":"73","author":"PW Wijermans","year":"1989","unstructured":"WijermansPW, RebelVI, OssenkoppeleGJ, HuijgensPC, LangenhujsenMMAC: Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: Reversal of the bleeding disorder by cell differentiation. Blood 73: 800?805, 1989","journal-title":"Blood"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.2830330204","volume":"33","author":"H Takahashi","year":"1990","unstructured":"TakahashiH, TatewakiW, WadaK, HananoM, ShibataA: Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 33: 90?95, 1990","journal-title":"Am J Hematol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.1989.tb06311.x","volume":"71","author":"B Bennett","year":"1989","unstructured":"BennettB, BoothNA, CrollA, DawsonAA: The bleeding disorder in acute promyelocytic leukemia: fibrinolysis due to u-PA rather than defibrination. Br J Haematol 71: 511?515, 1989","journal-title":"Br J Haematol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-105-6-873","volume":"105","author":"BS Schwartz","year":"1986","unstructured":"SchwartzBS, WilliamsEC, ConlanMG, MosherDF: Epsilon amino caproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency. Ann Int Med 105: 873?877, 1986","journal-title":"Ann Int Med"},{"key":"CR44","first-page":"1252","volume-title":"Hemostasis and Thrombosis: Basic principles and clinical practice","author":"EW Salzman","year":"1987","unstructured":"SalzmanEW, HirshJ: Prevention of venous thromboembolism In: ColmanRW, HirshJ, MarderVJ, SalzmanEW (eds) Hemostasis and Thrombosis: Basic principles and clinical practice. Lippincott, Philadelphia, pp 1252?1265, 1987"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1200\/JCO.1987.5.4.672","volume":"5","author":"G Fraschini","year":"1987","unstructured":"FraschiniG, JadejaJ, LawsonM, HolmesFA, CarrascoHC, WallaceS: Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 5: 672?678, 1987","journal-title":"J Clin Oncol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000658-198808000-00016","volume":"208","author":"GP Clagett","year":"1988","unstructured":"ClagettGP, ReischJS: Prevention of venous thromboembolism in general surgical patients. Ann Surg 208: 227?240, 1988","journal-title":"Ann Surg"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0002-9378(83)91205-X","volume":"145","author":"DL Clarke-Pearson","year":"1983","unstructured":"Clarke-PearsonDL, ColemanRE, SynanIS, HinshawW, CreasmanWT: Venous thromboembolism prophylaxis in gynecologic oncology: a prospective controlled trial of low dose heparin. Am J Obstet Gynecol 145: 606?613, 1983","journal-title":"Am J Obstet Gynecol"},{"key":"CR48","first-page":"92","volume":"63","author":"DL Clarke-Pearson","year":"1984","unstructured":"Clarke-PearsonDL, SynanIS, HinshawWM, ColemanE, CreasmanWT: Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 63: 92?98, 1984","journal-title":"Obstet Gynecol"},{"key":"CR49","first-page":"222","volume":"18","author":"DL Clarke-Pearson","year":"1984","unstructured":"Clarke-PearsonDL, CreasmanWT, ColemanRE, SynanIS, HinshawWM: Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. Gynecol Oncol 18: 222?232, 1984","journal-title":"Gynecol Oncol"},{"key":"CR50","first-page":"684","volume":"75","author":"DL Clarke-Pearson","year":"1990","unstructured":"Clarke-PearsonDL, DelongE, SynanIS, HinshawWM: A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol 75: 684?689, 1990","journal-title":"Obstet Gynecol"},{"key":"CR51","first-page":"230","volume":"83","author":"NP Coe","year":"1978","unstructured":"CoeNP, CollinsREC, KleinLA, BettmannMA, SkillmanJJ, ShapiroRM, SalzmanEW: Prevention of deep vein thrombosis in urological patients: a controlled randomized trial of low dose heparin and external pneumatic compression boots. Surgery 83: 230?234, 1978","journal-title":"Surgery"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00256865","volume":"5","author":"M Kutnowski","year":"1977","unstructured":"KutnowskiM, VandendrisM, SteinbergerR, KraytmanM: Prevention of postoperative deep vein thrombosis by low dose heparin in urologic surgery. Urolog Res 5: 123?125, 1977","journal-title":"Urolog Res"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.27.5.435","volume":"27","author":"AGG Turpie","year":"1977","unstructured":"TurpieAGG, GallusAS, BeattieWS, HirshJ: Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 27: 435?438, 1977","journal-title":"Neurology"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3171\/jns.1978.49.3.0378","volume":"49","author":"D Cerrato","year":"1978","unstructured":"CerratoD, ArianoC, FiacchinoF: Deep vein thrombosis and low dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49: 378?381, 1978","journal-title":"J Neurosurg"},{"key":"CR55","first-page":"354","volume":"83","author":"JJ Skillman","year":"1978","unstructured":"SkillmanJJ, CollinsREC, CoeNP, GoldsteinBS, ShapiroRM, ZervesNT, BettmannMA, SalzmanEW: Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery 83: 354?358, 1978","journal-title":"Surgery"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0049-3848(85)90105-7","volume":"39","author":"AGG Turpie","year":"1985","unstructured":"TurpieAGG, DoyleDJ, SaerensE, deBoerAC, TalbotC, McNameeJ, HirshJ: An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients. Thromb Res 39: 173?181, 1985","journal-title":"Thromb Res"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0049-3848(79)90171-3","volume":"15","author":"AGG Turpie","year":"1979","unstructured":"TurpieAGG, DelmoreT, HirshJ, HullR, GentonE, HiscoeC, GentM: Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res 15: 611?616, 1979","journal-title":"Thromb Res"},{"key":"CR58","first-page":"677","volume":"65","author":"RB Weiss","year":"1981","unstructured":"WeissRB, TormeyDC, HollandJF, WeinbergVE: Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep 65: 677?679, 1981","journal-title":"Cancer Treat Rep"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM198802183180703","volume":"318","author":"M Levine","year":"1988","unstructured":"LevineM, GentM, HirshJ, ArnoldA, GoodyearMD, HryniukW, DePauwS: The thrombogenic effect of anticancer drug therapy in women with Stage II breast cancer. N Engl J Med 318: 404?407, 1988","journal-title":"N Engl J Med"},{"key":"CR60","first-page":"25","volume":"8","author":"KI Pritchard","year":"1989","unstructured":"PritchardKI, PaterJ, PatersonAHJ, FineS: Thromboembolic complications related to chemotherapy. Proc Amer Soc Clin Oncol 8: 25, 1989 (Abstract)","journal-title":"Proc Amer Soc Clin Oncol"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9343(89)80604-7","volume":"87","author":"JG Wall","year":"1989","unstructured":"WallJG, WeissRB, NortonL, PerloffM, RiceMA, KorzunAH, WoodWC: Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B study. Amer J Med 87: 501?504, 1989","journal-title":"Amer J Med"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","volume":"9","author":"T Saphner","year":"1991","unstructured":"SaphnerT, TormeyDC, GrayR: Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9: 286?294, 1991","journal-title":"J Clin Oncol"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"FisherB, ConstantinoJ, RedmondC, PoissonR, BowmanD, CoutureJ: A randomized clinical trial evaluating Tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor positive tumors. N Engl J Med 320: 479?484, 1989","journal-title":"N Engl J Med"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R","volume":"54","author":"LT Goodnough","year":"1984","unstructured":"GoodnoughLT, SaitoH, ManniA, JonesPK, PearsonOH: Increased incidence of thromboembolism in Stage IV breast cancer patients treated with five-drug chemotherapy regimen: a study of 159 patients. Cancer 54: 1264?1268, 1984","journal-title":"Cancer"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","volume":"112","author":"MM Bern","year":"1990","unstructured":"BernMM, LokichJJ, WallachSR, BotheA, BenottiPN, ArkinCF, GrecoFA, HubermanM, MooreC: Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Int Med 112: 423?428, 1990","journal-title":"Ann Int Med"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(90)90093-S","volume":"89","author":"RL Edwards","year":"1990","unstructured":"EdwardsRL, KlausM, MatthewsE, McCullenC, BonaRD, RicklesFR: Heparin abolishes the chemotherapy-induced increases in plasma fibrinopeptide A levels. Am J Med 89: 25?28, 1990","journal-title":"Am J Med"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01307180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01307180\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01307180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T17:09:46Z","timestamp":1586192986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01307180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":66,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF01307180"],"URL":"https:\/\/doi.org\/10.1007\/bf01307180","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]}}}